Intrinsic Value

Not Available for VVOS

There is not enough data to reliably calculate the intrinsic value for Vivos Therapeutics Inc.

Do our valuations actually work? See backtest results .

Alternatives to VVOS

Fundamental Analysis

What Vivos Therapeutics Does

Health Care

Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). The company is headquartered in Littleton, Colorado and currently employs 268 full-time employees. The company went IPO on 2020-12-11. The firm's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA…

Headquarters
United States of America US
Employees
270
IPO date
Dec 11, 2020
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Latest Earnings Call

Q3 2026 · November 16, 2026

Vivos is shifting toward integrated sleep-care services and payer improvements, while tight liquidity and Nasdaq bid-price compliance remain key execution risks.

Open the earnings call
EPS
−$0.07
Expected
−$0.30
Surprise
+76.7%
Stock, next trading day
−3.0%
View Earnings Call

Vivos Therapeutics insiders are buying more than usual

Insider trading · Last trade on Jun 30, 2026

Sold $0 Nobody sold
Bought $1.9m 1 insider
Trades by date
Open insider trading

Past 12 months

Continue VVOS Research

Decided on Vivos Therapeutics? Get an email when VVOS reaches the price you’d buy at. Free with an account.

Back to Top